Friday, 10 Apr 2020

You are here

RheumNow Podcast- Half-Empty Flu (2.21.20)

Dr Jack Cush reviews the news and journal articles from the past week on RheumNow.com

  1. @philiprobinson has a nice metanalysis of Colchicine toxicity - 35 RCTs, 8659 pts. Incr risk of Diarrhea (17.9%; RR 2.4); GI events (17.6%; RR 1.7); Liver toxicity (1.9%; RR 1.6, ns); Muscle events (4.2%; RR 1.3, ns). no neuropathy, deaths, infections. https://t.co/3d9PmFCR9r
  2. According to the CDC, the overall estimated effectiveness of seasonal influenza vaccine for preventing medically attended, laboratory-confirmed influenza virus infection was 45%. https://t.co/G47odZd72v
  3. Important acronyms in both Ortho and Rheum. Dr Wm Bugbee at #RWCS2020 BARF: Blindless application of Radiologic Findings and VOMIT: Victim of Medical Imaging Technology. @RWCSmtg https://t.co/guqjPwkoFT
  4. A study of 319 WOMEN with RA shows a higher rate of depression (30% in RA) compared to healthy controls (12.4%) (p<0.001). Depressive symptoms were strongly associated with disease activity and disability (HAQ, p<0.005). https://t.co/JDRNrR8qMn
  5. Vitamin D levels are not associated with Fatigue! Study of 169 RA pts, 69% w/ a DAS28-CRP <3.2. with no/low correlation with serum 25(OH)D (r = −0.14); YET fatigue was significantly associated with RA disease activity, psychological distress and pain https://t.co/j1UkOGyKj7
  6. Slovenian National TB Registry (a non-endemic area w/ TB rate 6/100k similar to US). 2429 TNFi exposed (RA, AS, PsA)-6% required TB chemoprophylaxis; 6 RA and 2 PsA developed TB; 2 pts died. The TB incidence rate for TNF Rx pop was 45-51/100kPYs https://t.co/tam5I17QO1
  7. FDA has approved OTC voltaren (diclofenac) gel, now called Voltaren Arthritis Pain for arthritis & OA pain; it is not for immediate relief and may take up to 7 days to work. Pts should seek medical attention If they need to use this product for >21 days. https://t.co/qTcbPZDcqa
  8. Cross sectional study of 139 RA patients shows that severity of periodontal disease on dental exams was linearly associated with both the presence and levels of anti-CCP antibodies. https://buff.ly/38GR9eN
  9. Tofacitinib Effective in Refractory Still's Disease
  10. JAK Inhibitors Stimulate Osteoblasts
  11. Adverse Effects of Low-Dose Methotrexate from the CIRT Trial

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

Incubation Period for COVID-19

The incubation period for coronavirus disease 2019 (COVID-19) has important implications for surveillance and control activities. The Annals of Internal Medicine reports a pooled analysis of confirmed COVID-19 cases January 4, 2020 and February 24, 2020. The analyzed confirmed SARS-CoV-2 infection outside Hubei province, China.

COVID-19 Susceptibility: Why Do Some Become So Ill?

The differential susceptibility to COVID-19 infection is attributable to socioeconomic factors and genetic differences, that together with environmental factors, human-virus interactions, gender, perhaps blood type, and age-related senescence determine the immune response and the likelihood of developing disease.

NICE Guidelines on Managing Rheumatologic Conditions During COVID-19 Pandemic

On April 3rd, the National Institute for Health and Care Excellence (NICE) in the UK, published a rapid guideline for managing children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection.

RheumNow Podcast – Pandemic Numbers (4.3.20)

Dr. Jack Cush reviews the news on COVID-19 and FDA actions this past week. Be sure to check out:

CDC: Impact of Underlying Health Conditions Among COVID-19 Patients

The March 31 release of the Morbidity and Mortality Weekly Report (MMWR) reviews the impact of several key comorbidities, most commonly diabetes mellitus, chronic lung disease, and cardiovascular disease, as cofactors leading to worse outcomes with COVID-19 infections.  Below are experts from that report.